Heart rate as marker of sympathetic activity

Objective To determine the value of the supine heart rate as a marker of sympathetic tone by assessing, in a large group of subjects, the relationships between this parameter and two other indices of sympathetic activity, plasma norepinephrine and sympathetic nerve traffic. Patients and methods We studied 243 subjects aged 50.0 ± 12.1 years (mean ± SD). Of these, 38 were normotensive healthy controls, 113 subjects had untreated essential hypertension, 27 were obese normotensives and 65 had congestive heart failure. In each subject, over a 10 min supine period, we measured mean arterial pressure (Finapres), heart rate (electrocardiogram), venous plasma norepinephrine (high-performance liquid chromatography) and efferent postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve). Results In the whole study group, supine heart rate was correlated with both plasma norepinephrine (r = 0.32, P < 0.0001) and muscle sympathetic nerve activity (r = 0.38, P < 0.0001). This was also the case in the normotensive obese subjects and the heart failure subjects considered separately. Heart rate values were greater in the obese and the heart failure patients than in controls (75.1 ± 13.0 and 78.2 ± 13.0 versus 69.2 ± 11.6 beats/min; P < 0.05 and P < 0.001, respectively), as were plasma norepinephrine (362.7 ± 202 and 400.3 ± 217 versus 230.4 ± 126 pg/ml; P < 0.01 and P < 0.001, respectively) and muscle sympathetic nerve activity (44.1 ± 14.7 and 55.3 ± 14.3 versus 27.8 ± 11.0 bursts/min; P < 0.001 for both). In contrast, in the essential hypertensive subjects, no significant relationship was found between these three indices of sympathetic activity. Furthermore, in the hypertensives, the heart rate was not increased, at variance with the sympathetic nerve traffic, which was greater than in controls (36.2 ± 10.0 versus 27.8 ± 11.0 bursts/min, P < 0.001). Conclusions These data suggest that the supine heart rate can be regarded as a marker of intersubject differences in sympathetic tone, and that this is the case both in the general population and in those with cardiovascular diseases. Its value for this purpose is limited, however, and the limitations may be more evident in essential hypertension than in conditions such as obesity and heart failure.

[1]  G Mancia,et al.  Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. , 1998, Hypertension.

[2]  G. Jennings,et al.  Adrenergic nervous system in heart failure. , 1997, The American journal of cardiology.

[3]  G. Mancia Björn Folkow Award Lecture The sympathetic nervous system in hypertension , 1997, Journal of hypertension.

[4]  G. Jennings,et al.  Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. , 1997, Circulation.

[5]  G. Grassi,et al.  Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. , 1995, Circulation.

[6]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[7]  P. Vollenweider,et al.  Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.

[8]  G. Mancia,et al.  Reflex cardiovascular control in congestive heart failure. , 1992, The American journal of cardiology.

[9]  J Ludbrook,et al.  ON MAKING MULTIPLE COMPARISONS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , 1991, Clinical and experimental pharmacology & physiology.

[10]  S. Julius Changing role of the autonomic nervous system in human hypertension. , 1990, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  P. Lund-johansen Central haemodynamics in essential hypertension at rest and during exercise: a 20-year follow-up study. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[12]  G. Parati,et al.  Comparison of Finger and Intra‐arterial Blood Pressure Monitoring at Rest and During Laboratory Testing , 1989, Hypertension.

[13]  G. Jennings,et al.  Regional norepinephrine turnover in human hypertension. , 1989, Clinical and experimental hypertension. Part A, Theory and practice.

[14]  R. Gillum,et al.  The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. , 1988, American heart journal.

[15]  S. Julius,et al.  Sympathetic Hyperactivity in Early Stages of Hypertension: The Ann Arbor Data Set , 1988, Journal of cardiovascular pharmacology.

[16]  A. Mark,et al.  Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. , 1986, Circulation.

[17]  F. Bühler,et al.  Cardiac and Vascular &bgr;‐Adrenoceptor‐Mediated Responses Before and During Treatment with Bisoprolol or Atenolol , 1985, Journal of cardiovascular pharmacology.

[18]  G Mancia,et al.  Reflex control of the human cardiovascular system. , 1986, Reviews of physiology, biochemistry and pharmacology.

[19]  Arthur C. Guyton,et al.  Handbook of Physiology—The Cardiovascular System , 1985 .

[20]  M. Condorelli,et al.  Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. , 1983, Hypertension.

[21]  J. Izzo,et al.  Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. , 1981, Life sciences.

[22]  A. Vallbo,et al.  Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. , 1979, Physiological reviews.

[23]  P. Hjemdahl,et al.  Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. , 1979, Life sciences.

[24]  S. Julius,et al.  Altered Cardiac Responsiveness and Regulation in the Normal Cardiac Output Type of Borderline Hypertension , 1975, Circulation research.

[25]  J. Uther,et al.  Autonomic and Non‐Autonomic Circulatory Components in Essential Hypertension in Man , 1973, Circulation.

[26]  S. Julius,et al.  Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension , 1971, Circulation.